ChemicalBook >> CAS DataBase List >>ZA7371

ZA7371

CAS No.
1494675-86-3
Chemical Name:
ZA7371
Synonyms
ZA7371;AZ-7371;CS-1538;TBA-7371;DprE1-IN-1;AZ7371;AZ 7371;DprE1-IN-1 ZA7371;ZA 7371 TBA-7371;DprE1-IN-1 (AZ7371;AZ-7371(DprE1-IN-1)
CBNumber:
CB93060642
Molecular Formula:
C18H21N5O3
Molecular Weight:
355.39
MDL Number:
MFCD29477419
MOL File:
1494675-86-3.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-05-11 16:31:51

ZA7371 Properties

Boiling point 691.6±55.0 °C(Predicted)
Density 1.34±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 11 mg/mL (30.95 mM)
pka 12.79±0.46(Predicted)
form A crystalline solid
color White to off-white
FDA UNII R3T98GBE3C

ZA7371 price More Price(25)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 19310 AZ 7371 ≥98% 1494675-86-3 1mg $49 2026-04-30 Buy
Cayman Chemical 19310 AZ 7371 ≥98% 1494675-86-3 5mg $213 2026-04-30 Buy
Cayman Chemical 19310 AZ 7371 ≥98% 1494675-86-3 10mg $376 2026-04-30 Buy
Cayman Chemical 19310 AZ 7371 ≥98% 1494675-86-3 25mg $762 2026-04-30 Buy
ChemScene CS-5414 TBA-7371 99.61% 1494675-86-3 5mg $32 2026-06-04 Buy
Product number Packaging Price Buy
19310 1mg $49 Buy
19310 5mg $213 Buy
19310 10mg $376 Buy
19310 25mg $762 Buy
CS-5414 5mg $32 Buy

ZA7371 Chemical Properties,Uses,Production

Uses

TBA-7371 is an orally active and non-covalent inhibitor of Decaprenylphosphoryl-β-D-ribose oxidase (DprE1) of Mycobacterium tuberculosis (MIC=0.64 μg/mL). TBA-7371 can block the synthesis of arabinose in the bacterial cell wall, resulting in cell wall structural defects, thereby exerting an anti-tuberculosis effect. TBA-7371 can be used in the research of anti-tuberculosis drugs and has a synergistic bactericidal effect with Bedaquiline (HY-14881) and other drugs[1][2][3].

in vivo

TBA-7371 (100, 200 mg/kg; oral gavage; twice daily; 4-8 weeks) synergistically exerts bactericidal and fungicidal activity with Bedaquiline (HY-14881) and GSK2556286 (HY-147017) in the BALB/c mouse tuberculosis model[3].
TBA-7371 (50, 100, 200 mg/kg; oral gavage; twice daily; 8 weeks) significantly reduces bacterial burden in lung tissue after 8 weeks of treatment in the C3HeB/Fe J mouse tuberculosis model[3].

Animal Model:Female BALB/c mice (5-6 weeks old, specific pathogen-free) + subacute tuberculosis infection model induced by aerosol of *Mycobacterium tuberculosis* H37Rv[3]
Dosage:100 mg/kg, 200 mg/kg (0.5% carboxymethylcellulose + 0.1% Tween 80)
Administration:Oral gavage, twice daily (8 h apart), 5 days/week for 4-8 weeks; Combination with Bedaquiline (25 mg/kg) and GSK2556286 (50 mg/kg) (BGA regimen)
Result:At 100 or 200 mg/kg bid significantly increased bactericidal activity after 8 weeks, with lung CFU counts of 1.48 (200 mg/kg) and 1.78 (100 mg/kg), demonstrating superior sterilizing activity compared to two-drug combinations.
Animal Model:Female C3HeB/FeJ mice (8-10 weeks old, specific pathogen-free) + chronic tuberculosis infection model with caseous necrotic pulmonary lesions induced by aerosol of *Mycobacterium tuberculosis* Erdman[3]
Dosage:50 mg/kg, 100 mg/kg, 200 mg/kg (0.5% carboxymethylcellulose + 0.1% Tween 80)
Administration:Oral gavage, twice daily, 5 days/week for 8 weeks
Result:After 8 weeks, all dose groups showed significant reduction in lung bacterial burden compared to untreated controls.
The 100 and 200 mg/kg groups achieved approximately 1.5 log CFU reduction, with dose-dependent efficacy.
At 100 mg/kg bid exhibited consistent bactericidal activity, with higher drug retention in caseous lesions at trough concentrations.

References

[1] Gawad J, et al. Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1): challenging target for antitubercular drug discovery. Chem Cent J. 2018 Jun 23;12(1):72. DOI:10.1186/s13065-018-0441-2
[2] Robertson GT, et al. Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0058321. DOI:10.1128/AAC.00583-21
[3] Li S-Y, et al. Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis. Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0156223. DOI:10.1128/aac.01562-23

ZA7371 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 76)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Boyle Chemical Co., Ltd. sales@boylechem.com China 2915 55
Haoyuan Chemexpress Co., Ltd. 021-58950125 info@chemexpress.com China 7545 61
MedChemexpress LLC 021-58955995 sales@medchemexpress.cn United States 4853 58
HangZhou YuHao Chemical Technology Co., Ltd. 0571-82693216 info@yuhaochemical.com China 1999 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4861 55
Guangzhou Zhiya Chemdrugs Co.,Ltd 18122150900 sculk28@163.com China 645 55
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Shanghai QianYan Bio-technology Co., Ltd 02781293128 orders@biochemsafebuy.com China 9904 55
Shanghai Changyan Chem & Tech Co., Ltd. 021-20242659 18930833303 sales@changyanchem.cn China 4998 55
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62

View Lastest Price from ZA7371 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
TBA-7371 pictures 2026-05-11 TBA-7371
1494675-86-3
$41.00-123.00 99.74% 10g TargetMol Chemicals Inc.
N-(2-Hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide pictures 2020-01-02 N-(2-Hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide
1494675-86-3
$1.00 1KG Min98% HPLC Career Henan Chemical Co
  • TBA-7371 pictures
  • TBA-7371
    1494675-86-3
  • $41.00-123.00
  • 99.74%
  • TargetMol Chemicals Inc.

ZA7371 Spectrum

N-(2-Hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide ZA7371 DprE1-IN-1 AZ-7371 AZ-7371(DprE1-IN-1) TBA-7371 DprE1-IN-1 ZA7371 AZ7371;AZ 7371 CS-1538 1H-Pyrrolo[3,2-b]pyridine-3-carboxamide, N-(2-hydroxyethyl)-1-[(6-methoxy-5-methyl-4-pyrimidinyl)methyl]-6-methyl- DprE1-IN-1 (AZ7371 TBA-7371,tuberculosis,Inhibitor,noncovalent,antituberculosis,DprE1,Bacterial,inhibit,TBA 7371,TBA7371,antitubercular ZA 7371 TBA-7371 1494675-86-3